This approval was based on the SURPASS clinical trial program, which demonstrated superior glycemic control compared to placebo, semaglutide 1 mg, and insulin degludec across multiple studies
Real-World Evidence Supports the Research Beyond formal clinical trials, large-scale reviews of medical records provide additional support
L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats [PMID: 12904603] Laboratory literature summary: L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats
It is also FDA-approved to lower the risk of major adverse cardiovascular events (cardiovascular death, heart attack, and stroke) in adults with Type 2 diabetes and heart disease
The plasma center staff told Craythorn she would be compensated for her time but would not be able to donate for about three weeks
Ingredient lists that do not match marketing emphasis